DRT DIRTT Environmental Solutions Ltd.
DIRTT Environmental Solutions Ltd. engages in the industrialized construction business in the United States and Canada. The company designs and manufactures interior spaces; and offers ICE software, a platform that designs, visualizes, organizes, configures, prices, manufactures, assembles, and installs construction projects. It also provides solid, glass, combination, leaf folding, and headwalls, as well as doors, prefabricated module, casework, timer, electrical, networks, and access floors. The company serves healthcare, education, financial services, government and military, manufacturing, non-profit, energy, professional services, retail, technology, and hospitality industries. It sells its products and solutions through a network of construction partners, local sales representatives, internal industry specialists, business development professionals, and a construction partner support team. The company was incorporated in 2003 and is headquartered in Calgary, Canada.…
Industry Peers
Engineering & ConstructionKey Statistics
About DIRTT Environmental Solutions (TSE: DRT)
›
DIRTT Environmental Solutions (TSE: DRT) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Engineering & Construction industry, part of the Industrials sector, and reports about 756 employees.
The shares were at 0.7800 CAD on 20 November 2026, down 19.6% over 52 weeks. Its 52-week range is 0.6800 CAD to 1.080 CAD: the price is 27.8% below the high and 14.7% above the low.
At a market capitalisation of 152.98M CAD, it trades at 11.1 times trailing earnings and 11.5 times forward earnings. The median trailing P/E of its 19 largest Engineering & Construction peers is 23.6, a discount of 53% for DRT.
DIRTT Environmental Solutions reports return on equity of -50.6%, an operating margin of 4.5% and revenue up 18.6% year over year.
Its debt exceeds its cash by 20.20M USD, a debt-to-equity ratio of 1.61. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. One analyst covers the stock, with an average rating of Buy; their mean price target of 1.068 CAD is 37.0% above the current price. The next earnings report is expected on 24 February 2027.